Patheon Nv (PTHN)
34.98 unch (unch) 09/01/17 [NYSE]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Sep 1st, 2017
Results
download Want to compare other data? Select Fields| Symbol | PTHN | STVN | GRFS | ||
| Company | Patheon Nv | Stevanato Group S.P.A. | Grifols S.A. ADR | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 35.00 | 20.40 | 7.06 | ||
| High | 35.02 | 21.01 | 7.09 | ||
| Low | 34.98 | 20.40 | 6.90 | ||
| Last | 34.98 | 20.86 | 6.95 | ||
| Change | unch | -0.14 | -0.13 | ||
| % Change | unch | -0.67% | -1.84% | ||
| Volume | 229,700 | 163,300 | 1,014,400 | ||
| 20-Day Average Volume | 142,495 | 324,675 | 1,015,640 | ||
| Previous Close | 34.98 | 21.00 | 7.08 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 34.97 | 21.10 | 6.98 | ||
| 20-Day Raw Stochastic | 37.50% | 60.09% | 55.47% | ||
| 20-Day Relative Strength | 62.24% | 48.46% | 44.86% | ||
| Weighted Alpha | +15.00 | -14.69 | -4.26 | ||
| Today's Opinion | N/A | 40% Buy | 88% Sell | ||
| Previous Opinion | N/A | 40% Buy | 72% Sell | ||
| Last Month's Opinion | N/A | 8% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 08/25/17 | -4.36% since 04/23/25 | -3.34% since 04/23/25 | ||
| Low | 34.98 on 09/01/17 | 20.40 on 04/30/25 | 6.90 on 04/30/25 | ||
| High | 35.13 on 08/31/17 | 22.03 on 04/24/25 | 7.34 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | +0.14% since 08/01/17 | +2.81% since 03/28/25 | -4.40% since 03/28/25 | ||
| Low | 34.86 on 08/02/17 | 18.18 on 04/09/25 | 6.19 on 04/09/25 | ||
| High | 35.13 on 08/31/17 | 22.64 on 04/15/25 | 7.56 on 04/03/25 | ||
| 3-Month | |||||
| %Chg | +0.63% since 06/01/17 | -4.88% since 01/30/25 | +0.58% since 01/30/25 | ||
| Low | 34.59 on 06/09/17 | 17.81 on 03/03/25 | 6.19 on 04/09/25 | ||
| High | 35.13 on 08/31/17 | 23.00 on 03/24/25 | 8.81 on 03/06/25 | ||
| 6-Month | |||||
| %Chg | +10.17% since 03/01/17 | +10.49% since 10/30/24 | -20.75% since 10/30/24 | ||
| Low | 23.72 on 03/16/17 | 17.49 on 11/18/24 | 6.19 on 04/09/25 | ||
| High | 35.13 on 08/31/17 | 24.90 on 12/13/24 | 9.96 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,076,997 | 6,359,703 | 4,867,890 | ||
| Shares Outstanding, K | 145,140 | 302,843 | 687,555 | ||
| Annual Sales | 1,866,700,000 | 1,194,680,000 | 7,804,520,000 | ||
| Annual Net Income | 31,700,000 | 127,450,000 | 169,800,000 | ||
| Last Quarter Sales | 483,400,000 | 353,380,000 | 1,971,530,000 | ||
| Last Quarter Net Income | 27,600,000 | 51,800,000 | 56,840,000 | ||
| 60-Month Beta | 3.38 | 0.52 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.20 on 06/08/17 | 0.20 on 03/06/25 | 0.02 on 07/30/24 | ||
| Latest Earnings Date | 08/02/18 | 05/08/25 | 03/06/25 | ||
| Most Recent Dividend | N/A | N/A | 0.370 on 06/03/21 | ||
| Next Ex-Dividends Date | N/A | N/A | 06/03/21 | ||
| Ratios | |||||
| Price/Earnings ttm | 45.43 | 41.50 | 0.00 | ||